<DOC>
	<DOCNO>NCT00136617</DOCNO>
	<brief_summary>The purpose study compare fixed-schedule therapy versus symptom-triggered therapy alcohol withdrawal syndrome medical outpatient . Objectives : - Self-governance monitoring AWS ( alcohol withdrawal syndrome ) symptoms medication - Clinically control trial two regimens medical treatment alcohol withdrawal syndrome - Outpatient treatment alcohol withdrawal syndrome</brief_summary>
	<brief_title>Outpatient Treatment Alcohol Withdrawal Syndrome</brief_title>
	<detailed_description>The objective study compare fixed-schedule therapy versus symptom-triggered therapy alcohol withdrawal syndrome medical outpatient . Objectives : - Self-governance monitoring AWS ( alcohol withdrawal syndrome ) symptoms medication - Clinically control trial two regimens medical treatment alcohol withdrawal syndrome - Outpatient treatment alcohol withdrawal syndrome Patients Methods : This study prospective analysis patient admit medical outpatient clinic August 25 , 2003 July 1 , 2006 , experience AWS . This study conduct Copenhagen Hospital Corporation Copenhagen , Denmark . Patients divide two randomized group : symptom-triggered treatment versus fixed-schedule treatment ( know ) chlordiazepoxide . They diagnose AWS accord DSM-IV ( Diagnostic Statistical Manual Mental Disorders Fourth Edition ) . They diagnose alcohol dependence accord ICD-10 ( International Statistical Classification Diseases Health Related Problems ) . Methods : One hundred fifty consecutive patient fulfill inclusion criterion exclusion criterion offer participate study , i.e . also patient detoxify home admission . Patients score accord DSM-IV AWS ICD-10 alcohol dependence , fill SAWS ( Short Alcohol Withdrawal Scale ) . The score 12 significant number split patient mild moderate AWS . Randomization do Research Unit . Patients treat traditionally fixed-schedule therapy ( day 1 , 200mg , chlordiazepoxide decrease 25 mg day ) new symptom-triggered therapy ( 300 mg , chlordiazepoxide day ) . For 10 day , patient monitor ten day accord SAWS . They ask mental condition day 1-14 every third month use World Health Organization ( WHO ) -5 schedule . On day 10 fill adverse reaction questionnaire chlordiazepoxide DTSQ ( Diabetes Treatment Satisfaction Questionnaire ) ASI ( Addiction Severity Index ) every third month . Relapses intake alcohol year monitor .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Chlordiazepoxide</mesh_term>
	<criteria>Patients age 18 Fulfilled inform consent Abstained alcohol within last 72 hour . Agree treatment regimen . Abstinence 10 day ( monitor medication period ) , i.e . treatment disulfiram oral alcometer test every attendance ( Lion Alcometer SD2 ) . Oral alcoholmeter test &gt; 0.1 . Treatment AWS within last week 3 early attempt outpatient detoxification within last 2 month without success . Allergy adverse reaction chlordiazepoxide Treatment medication interaction chlordiazepoxide Psychiatric comorbidity within last year , dependence drug except nicotine dependence Medically severe comorbidity , especially severe liver insufficiency Severe cardiovascular disease , NIDDM IDDM . A history within last year seizure delirium tremens . Patients cooperative term cooperation understand Danish language . Females fertile age without safe contraception , ( i.e . IUD , hormone tablet sterilisation ) also pregnant breastfeed woman exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Short Alcohol Withdrawal Scale</keyword>
	<keyword>Documentation</keyword>
</DOC>